BCL2L2 and cancer: Notably, BCL-w-mediated BAX inhibition is essential for cell invasion as a variant of BCL-w (BCL-wG94A) that does not bind to BAX failed to stimulate ROS production and cell invasion18 as well as cancer cell intravasation in an in vivo model of lung cancer147.